Wenhui Yang1, Zhirui Ding2, Ting Dai2, Fang Peng2, John X Zhang3. 1. Department of Psychology, Hunan Normal University, Changsha, China. Electronic address: yangwh110@163.com. 2. Department of Psychology, Hunan Normal University, Changsha, China. 3. Department of Psychology, Fudan University, Shanghai, China.
Abstract
BACKGROUND AND OBJECTIVES:Negative attentional biases are often considered to have a causal role in the onset and maintenance of depressive symptoms. This suggests that reduction of such biases may be a plausible strategy in the treatment of depressive symptoms. The present clinical randomized controlled trial examined long-term effects of a computerized attention bias modification (ABM) procedure on individuals with elevated depressive symptoms. METHODS: In a double-blind study design, 77 individuals with ongoing mild to severe symptoms of depression were randomly assigned to one of three conditions: 1) ABM training (n = 27); 2) placebo (n = 27); 3) assessment-only (n = 23). In both the ABM and placebo conditions, participants completed 8 sessions of 216-trials (1728 in total) during a 2-week period. Assessments were conducted at pre-training and post-training (0, 2, 4, 8-week, 3, 7-month follow-ups). Change in depressive symptoms and restoration of asymptomatic level were the primary outcome measures. RESULTS: In the ABM, but not the other two conditions, significant reductions in depressive symptoms were found at post-training and maintained during the 3-month follow-up. Importantly, more participants remained asymptomatic in the ABM condition, as compared to the other two conditions, from post-training to 7-month follow-up. ABM also significantly reduced secondary outcome measures including rumination and trait anxiety, and notably, the ABM effect on reducing depressive symptoms was mediated by rumination. LIMITATION: Generalization of the findings may be limited because the present sample included only college students. CONCLUSIONS: The ABM effect on reducing depressive symptoms was maintained for at least 3-month duration in individuals with elevated depressive symptoms, and these results suggest that ABM may be a useful tool for the prevention of depressive symptoms. CLINICALTRIALS.GOV: NCT01628016.
RCT Entities:
BACKGROUND AND OBJECTIVES: Negative attentional biases are often considered to have a causal role in the onset and maintenance of depressive symptoms. This suggests that reduction of such biases may be a plausible strategy in the treatment of depressive symptoms. The present clinical randomized controlled trial examined long-term effects of a computerized attention bias modification (ABM) procedure on individuals with elevated depressive symptoms. METHODS: In a double-blind study design, 77 individuals with ongoing mild to severe symptoms of depression were randomly assigned to one of three conditions: 1) ABM training (n = 27); 2) placebo (n = 27); 3) assessment-only (n = 23). In both the ABM and placebo conditions, participants completed 8 sessions of 216-trials (1728 in total) during a 2-week period. Assessments were conducted at pre-training and post-training (0, 2, 4, 8-week, 3, 7-month follow-ups). Change in depressive symptoms and restoration of asymptomatic level were the primary outcome measures. RESULTS: In the ABM, but not the other two conditions, significant reductions in depressive symptoms were found at post-training and maintained during the 3-month follow-up. Importantly, more participants remained asymptomatic in the ABM condition, as compared to the other two conditions, from post-training to 7-month follow-up. ABM also significantly reduced secondary outcome measures including rumination and trait anxiety, and notably, the ABM effect on reducing depressive symptoms was mediated by rumination. LIMITATION: Generalization of the findings may be limited because the present sample included only college students. CONCLUSIONS: The ABM effect on reducing depressive symptoms was maintained for at least 3-month duration in individuals with elevated depressive symptoms, and these results suggest that ABM may be a useful tool for the prevention of depressive symptoms. CLINICALTRIALS.GOV: NCT01628016.
Authors: Kean J Hsu; Kayla Caffey; Derek Pisner; Jason Shumake; Semeon Risom; Kimberly L Ray; Jasper A J Smits; David M Schnyer; Christopher G Beevers Journal: Contemp Clin Trials Date: 2018-10-26 Impact factor: 2.226
Authors: Eva Hilland; Nils I. Landrø; Catherine J. Harmer; Michael Browning; Luigi A. Maglanoc; Rune Jonassen Journal: J Psychiatry Neurosci Date: 2020-01-01 Impact factor: 6.186
Authors: Alexandra K Gold; Rebecca E Montana; Louisa G Sylvia; Andrew A Nierenberg; Thilo Deckersbach Journal: Curr Behav Neurosci Rep Date: 2016-10-06
Authors: Rachel Montagner; Karin Mogg; Brendan P Bradley; Daniel S Pine; Marcelo S Czykiel; Euripedes Constantino Miguel; Luis A Rohde; Gisele G Manfro; Giovanni A Salum Journal: Eur Child Adolesc Psychiatry Date: 2015-11-07 Impact factor: 4.785
Authors: Kean J Hsu; Jason Shumake; Kayla Caffey; Semeon Risom; Jocelyn Labrada; Jasper A J Smits; David M Schnyer; Christopher G Beevers Journal: Psychol Med Date: 2021-03-26 Impact factor: 10.592